Whilst obesity usually gives rise to an increase in blood pro-inflammatory cytokines [21,22] and an altered lipid profile [23,24], the association between low levels of adiponectin and type 2 diabetes remained unchanged after adjusting for inflammation and dyslipidemia markers [25]. Here, ADIPOQ is linked to metabolic syndrome.